TWIST1 and neoplasm: Moreover, the cumulative OS at the end of the study for this group of patients was higher than the cumulative OS in patients at stage II and high expression levels of TWIST1. These preliminary observations could support the idea of TWIST1 expression as a tumor indicator at stage II, which could help select patients at greater risk who might benefit from adjuvant chemotherapy.